Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Vance

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
JAAD Case Reports|November 21, 2018
Ustekinumab-associated disseminated verrucaeMary E Anderson, Dawn Queen, Stephen L Vance, et al.
JAAD Case Reports|September 8, 2017
Delayed-onset vemurafenib-induced panniculitisStephen L Vance, Hannah M Singer, David Silvers, et al.
JAAD Case Reports|December 22, 2017
Bullous drug eruption with leukemic cell infiltrate in the setting of new-onset acute myeloid leukemiaTrisha Khanna, Stephen L Vance, David N Silvers, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
JAAD Case Reports|November 21, 2018
Ustekinumab-associated disseminated verrucaeMary E Anderson, Dawn Queen, Stephen L Vance, et al.
JAAD Case Reports|September 8, 2017
Delayed-onset vemurafenib-induced panniculitisStephen L Vance, Hannah M Singer, David Silvers, et al.
JAAD Case Reports|December 22, 2017
Bullous drug eruption with leukemic cell infiltrate in the setting of new-onset acute myeloid leukemiaTrisha Khanna, Stephen L Vance, David N Silvers, et al.
Pageof 1